Announced Fri, 10 Jul · 13:02 IST
Aurobindo Pharma sets up new manufacturing subsidiary in Indonesia
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.2%1-day move
₹1582.70
prior close
₹1564.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.0-0.1+0.0-2.2-1.9-2.2-2.1-3.0+0.1————
Up moveDown movePending
AI summary
Aurobindo Pharma's stepdown subsidiary PT Aurogen Pharma Indonesia has set up a new wholly owned unit, PT Auro Pharm Indonesia, in Indonesia on July 1, 2026. The new entity will undertake pharmaceutical manufacturing operations. Initial subscription is IDR 20 billion for 2000 equity shares of IDR 10 million each, paid in cash. No regulatory approvals needed.
Likely market impact
Expands manufacturing footprint in Indonesia, supports long-term growth in Southeast Asian pharma markets.